ACADIA Pharmaceuticals Inc. financial reports, ACADIA Pharmaceuticals Inc. annual revenue in 2024. When does ACADIA Pharmaceuticals Inc. report revenue?
ACADIA Pharmaceuticals Inc. total revenue, net income and dynamics of changes in Euro today
Net revenue of ACADIA Pharmaceuticals Inc. on 30/06/2021 amounted to 115 221 000 €. The dynamics of ACADIA Pharmaceuticals Inc. net income rose by 22 577 000 €. The assessment of the dynamics of ACADIA Pharmaceuticals Inc. net income was made in comparison with the previous report. These are the main financial indicators of ACADIA Pharmaceuticals Inc.. Chart of online financial report of ACADIA Pharmaceuticals Inc.. The financial report schedule from 31/03/2019 to 30/06/2021 is available online. Information on ACADIA Pharmaceuticals Inc. net income on the chart on this page is drawn in blue bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
107 503 612.64 €
+38.48 % ↑
-40 932 564.29 €
-
31/03/2021
99 417 119.63 €
+69.24 % ↑
-61 997 379.41 €
-
31/12/2020
112 902 072.15 €
+23.07 % ↑
-62 288 481.96 €
-
30/09/2020
112 500 873.12 €
+27.48 % ↑
-78 989 557.86 €
-
31/12/2019
91 740 222.85 €
-
-49 483 701.76 €
-
30/09/2019
88 250 724.31 €
-
-39 166 355.54 €
-
30/06/2019
77 632 012.31 €
-
-51 261 106.76 €
-
31/03/2019
58 742 069.14 €
-
-79 590 423.38 €
-
Show:
to
ACADIA Pharmaceuticals Inc. financial report charts
The dates of the latest financial statements of ACADIA Pharmaceuticals Inc.: 31/03/2019, 31/03/2021, 30/06/2021. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of ACADIA Pharmaceuticals Inc. is 30/06/2021. Gross profit ACADIA Pharmaceuticals Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit ACADIA Pharmaceuticals Inc. is 102 696 000 €
ACADIA Pharmaceuticals Inc. quarterly report dates
Cost of revenue ACADIA Pharmaceuticals Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue ACADIA Pharmaceuticals Inc. is 12 525 000 € Total revenue ACADIA Pharmaceuticals Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue ACADIA Pharmaceuticals Inc. is 115 221 000 € Operating income ACADIA Pharmaceuticals Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income ACADIA Pharmaceuticals Inc. is -43 709 000 €
Net income ACADIA Pharmaceuticals Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income ACADIA Pharmaceuticals Inc. is -43 871 000 € Current assets ACADIA Pharmaceuticals Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets ACADIA Pharmaceuticals Inc. is 645 730 000 € Total assets ACADIA Pharmaceuticals Inc. refers to the total amount of assets owned by a person or entity. Total assets ACADIA Pharmaceuticals Inc. is 724 429 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
95 817 524.62 €
41 882 379.67 €
99 264 104.19 €
-4 018 521.45 €
109 230 634.51 €
25 448 147.78 €
10 160 598.69 €
5 090 562.58 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
11 686 088.03 €
57 534 739.97 €
13 637 967.96 €
116 519 394.56 €
-17 490 411.67 €
62 802 576.53 €
67 471 413.62 €
53 651 506.56 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
107 503 612.64 €
99 417 119.63 €
112 902 072.15 €
112 500 873.12 €
91 740 222.85 €
88 250 724.31 €
77 632 012.31 €
58 742 069.14 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-40 781 414.89 €
-62 299 678.21 €
-13 400 047.60 €
-80 145 570.88 €
-52 621 451.38 €
-42 378 746.84 €
-53 267 101.91 €
-81 764 362.31 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-40 932 564.29 €
-61 997 379.41 €
-62 288 481.96 €
-78 989 557.86 €
-49 483 701.76 €
-39 166 355.54 €
-51 261 106.76 €
-79 590 423.38 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
46 292 769.94 €
46 292 769.94 €
46 292 769.94 €
46 292 769.94 €
76 134 513.60 €
76 134 513.60 €
76 134 513.60 €
76 134 513.60 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
148 285 027.53 €
161 716 797.85 €
126 302 119.75 €
192 646 444 €
144 361 674.23 €
130 629 471.15 €
130 899 114.22 €
140 506 431.45 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
602 479 650.33 €
628 841 225.66 €
669 550 797.94 €
681 304 063.47 €
709 329 215.25 €
692 609 478.93 €
407 674 195.74 €
444 496 802.53 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
675 907 470.01 €
704 592 267.63 €
730 197 162.94 €
742 371 220.94 €
730 726 185.84 €
714 307 815.31 €
430 013 517.54 €
467 541 488.21 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
249 075 554.08 €
284 092 765.23 €
304 190 970.59 €
422 053 915.39 €
176 975 423.28 €
359 655 336.95 €
69 446 619.07 €
91 022 729.70 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
69 814 229.35 €
63 206 574.62 €
59 539 802.09 €
69 960 713.64 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
78 418 549.01 €
71 186 703.24 €
67 148 588.35 €
77 206 554.73 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
10.73 %
9.97 %
15.62 %
16.51 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
527 005 715.60 €
542 650 611.73 €
585 012 564.19 €
611 004 663.21 €
652 307 636.84 €
643 121 112.07 €
362 864 929.19 €
390 334 933.48 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-27 717 254.85 €
-17 588 378.87 €
-35 825 207.34 €
-59 876 622.68 €
Last revenue report of ACADIA Pharmaceuticals Inc. was 30/06/2021. According to last financial report total revenue in ACADIA Pharmaceuticals Inc. was 107 503 612.64 Euro and changed by +38.48% since last year. Net income in ACADIA Pharmaceuticals Inc. was -40 932 564.29 € in last quartal, net income changes to 0%.
Current cash ACADIA Pharmaceuticals Inc. - the sum of all of the cash a company has on the date of report. Current cash ACADIA Pharmaceuticals Inc. is 266 956 000 €
ACADIA Pharmaceuticals Inc. stocks data
DR6.F stock price
ACADIA Pharmaceuticals Inc. stock price today, DR6.F stock quote.
